(Q37886276)

English

Glucagon-like peptide-1 receptor agonists versus insulin in inadequately controlled patients with type 2 diabetes mellitus: a meta-analysis of clinical trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 August 2017

0 references

1 reference

Europe PubMed Central

Glucagon-like peptide-1 receptor agonists versus insulin in inadequately controlled patients with type 2 diabetes mellitus: a meta-analysis of clinical trials (English)

1 reference

Europe PubMed Central

24 August 2017

type 2 diabetes

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Y Wang

1

1 reference

Europe PubMed Central

24 August 2017

L Li

2

1 reference

Europe PubMed Central

24 August 2017

M Yang

3

1 reference

Europe PubMed Central

24 August 2017

H Liu

4

1 reference

Europe PubMed Central

24 August 2017

G Boden

5

1 reference

Europe PubMed Central

24 August 2017

G Yang

6

1 reference

Europe PubMed Central

24 August 2017

publication date

1 November 2011

1 reference

Europe PubMed Central

24 August 2017

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

24 August 2017

13

1 reference

Europe PubMed Central

24 August 2017

972-981

1 reference

Europe PubMed Central

24 August 2017

11

1 reference

Europe PubMed Central

24 August 2017

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

The prevention and treatment of obesity. Application to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Incretins, insulin secretion and Type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Initiate Insulin by Aggressive Titration and Education (INITIATE): a randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Importance of Weight Management in Type 2 Diabetes: Review with Meta-analysis of Clinical Studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Glucagon-like peptide-1 analog and insulin combination therapy in the management of adults with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Exenatide therapy in insulin-treated type 2 diabetes and obesity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Further improvement in postprandial glucose control with addition of exenatide or sitagliptin to combination therapy with insulin glargine and metformin: a proof-of-concept study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01436.X

21 January 2018

Identifiers

10.1111/J.1463-1326.2011.01436.X

1 reference

Europe PubMed Central

24 August 2017

1 reference

Europe PubMed Central

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37886276&oldid=2088603267"